New Problem for Pathologists and Physicians: Should Patients Be Told about Incidental Findings from Clinical Laboratory Tests?

Pathologists and clinical laboratory managers will need a strategy for handling incidental findings When a genetic test for a certain type of cancer provides additional information that could affect the patient’s health, what is the ethical course of action for pathologists and clinical laboratory scientists? Should this information be disclosed to the physician who ordered that cancer test? In turn, should that physician inform his or her patient about these “incidental findings?” All medical...

Pathology and Clinical Laboratory Groups Voice Concerns about Two Proposed Genetic Test Registries

Separate genetic and molecular test registries proposed by the National Institutes of Health and by Palmetto GBA draw detailed public comments from medical lab groups Registries for genetic tests and molecular diagnostic assays don’t seem to be going over well with clinical laboratories and pathology groups. Two different genetic test registries are drawing criticisms from pathologists and laboratory medicine professionals. One molecular test registry was proposed last year by the National...
;